marimastat

DRUG5 trials

Sponsors

ILEX Oncology Services, Incorporated, Eastern Cooperative Oncology Group, NCIC Clinical Trials Group, Boston Children's Hospital, Liverpool School of Tropical Medicine

Conditions

Breast CancerLung CancerSnakebiteVascular Anomalies

Phase 1

Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.

CompletedNCT00261391

Boston Children's HospitalVascular Anomalies

Start: 2000-10-31End: 2007-10-31Target: 9Updated: 2008-01-09

Phase 2

Trial of Oral Community SVMP INhibitors for Snakebite

Not yet recruitingNCT07500233

Liverpool School of Tropical MedicineSnakebite

Start: 2027-01-01End: 2028-12-01Target: 504Updated: 2026-05-12

Phase 3

Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer

CompletedNCT00003011

NCIC Clinical Trials GroupLung Cancer

Start: 1997-01-31End: 2008-12-15Updated: 2020-04-03

Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy

CompletedNCT00003010

Eastern Cooperative Oncology GroupBreast Cancer

Start: 1997-12-02Target: 334Updated: 2023-06-15

Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer

CompletedNCT00002911

ILEX Oncology Services, IncorporatedLung Cancer

Start: 1996-12-31End: 2004-05-31Updated: 2013-12-18